CardioPharmaGENET (CA24165): A COST Action network for advancing cardiovascular pharmacogenomics and precision medicine Memorandum of Understanding
The Memorandum of Understanding (MoU) of CardioPharmaGENET (CA24165) has been published in the Journal of Molecular and Cellular Cardiology Plus. The publication presents the COST Action network and its mission to advance cardiovascular pharmacogenomics and precision medicine through multidisciplinary collaboration, knowledge exchange, capacity building, and translation of research into clinical practice.
Read the full publication: Journal of Molecular and Cellular Cardiology Plus
